439 related articles for article (PubMed ID: 34325939)
1. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
[TBL] [Abstract][Full Text] [Related]
2. Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.
Yang T; Hu LY; Li ZL; Liu K; Wu H; Xing H; Lau WY; Pawlik TM; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Li C; Wang MD; Wu MC; Shen F
J Gastrointest Surg; 2020 Feb; 24(2):320-329. PubMed ID: 30617773
[TBL] [Abstract][Full Text] [Related]
3. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
[TBL] [Abstract][Full Text] [Related]
4. Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma.
Xiong KG; Lin TS; Kong JF; Lin QB; Chen LF; Ke KY
Medicine (Baltimore); 2023 Mar; 102(9):e33062. PubMed ID: 36862923
[TBL] [Abstract][Full Text] [Related]
5. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
[TBL] [Abstract][Full Text] [Related]
6. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
[TBL] [Abstract][Full Text] [Related]
7. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
8. Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma.
Jung YB; Yoo JE; Han DH; Kim KS; Choi JS; Kim DY; Park YN; Choi GH
HPB (Oxford); 2021 Jul; 23(7):1113-1122. PubMed ID: 33309568
[TBL] [Abstract][Full Text] [Related]
9. Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.
Sasaki K; Shindoh J; Nishioka Y; Margonis GA; Sugawara T; Andreatos N; Hashimoto M; Pawlik TM
J Gastrointest Surg; 2017 Mar; 21(3):487-495. PubMed ID: 28050767
[TBL] [Abstract][Full Text] [Related]
10. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.
Benhammou JN; Aby ES; Shirvanian G; Manansala K; Hussain SK; Tong MJ
Sci Rep; 2020 Jun; 10(1):9902. PubMed ID: 32555268
[TBL] [Abstract][Full Text] [Related]
11. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma.
D'Silva M; Cho JY; Han HS; Yoon YS; Lee HW; Lee JS; Lee B; Kim M
Surg Oncol; 2022 May; 41():101730. PubMed ID: 35231745
[TBL] [Abstract][Full Text] [Related]
12. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME
Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425
[TBL] [Abstract][Full Text] [Related]
13. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
14. Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: A propensity-score matched and structural equation modelling study.
Kabir T; Syn NL; Tan ZZX; Tan HJ; Yen C; Koh YX; Kam JH; Teo JY; Lee SY; Cheow PC; Chow PKH; Chung AYF; Ooi LL; Chan CY; Goh BKP
Eur J Surg Oncol; 2020 Sep; 46(9):1756-1765. PubMed ID: 32345496
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
[TBL] [Abstract][Full Text] [Related]
16. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
17. Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma.
Chen VL; Yeh ML; Yang JD; Leong J; Huang DQ; Toyoda H; Chen YL; Guy J; Maeda M; Tsai PC; Huang CF; Yasuda S; Le AK; Dang H; Giama NH; Ali HA; Zhang N; Wang X; Jun DW; Tseng CH; Hsu YC; Huang JF; Dai CY; Chuang WL; Zhu Q; Dan YY; Schwartz M; Roberts LR; Yu ML; Nguyen MH
Hepatol Commun; 2021 Jan; 5(1):122-132. PubMed ID: 33437906
[TBL] [Abstract][Full Text] [Related]
18. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of perioperative and long-term outcomes of patients with hepatocellular carcinoma: Nonalcoholic fatty liver disease versus viral hepatitis.
Matsumoto T; Shiraki T; Tanaka G; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
World J Surg; 2024 May; 48(5):1219-1230. PubMed ID: 38468392
[TBL] [Abstract][Full Text] [Related]
20. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
Kao WY; Su CW; Chau GY; Lui WY; Wu CW; Wu JC
World J Surg; 2011 Apr; 35(4):858-67. PubMed ID: 21207029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
